ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D958. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $941,160 | +3.0% | 26,400 | +33.3% | 0.00% | – |
| Q2 2023 | $913,374 | -62.0% | 19,800 | -67.0% | 0.00% | -100.0% |
| Q1 2023 | $2,406,000 | -43.2% | 60,000 | -34.4% | 0.00% | -50.0% |
| Q4 2022 | $4,234,562 | +79.4% | 91,400 | +60.4% | 0.00% | +100.0% |
| Q3 2022 | $2,360,000 | +176.7% | 57,000 | +298.6% | 0.00% | – |
| Q2 2022 | $853,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 16,200 | $649,620 | 0.00% |
| JANE STREET GROUP, LLC | 60,000 | $2,406,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3,200 | $128 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |